Dr. Reza N. Mostofi, MD

Dr. Mostofi practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Mostofi's NPI, 1972786895, was assigned on December 13, 2007. Dr. Mostofi graduated from St. George's University School of Medicine in 2003. Dr. Mostofi holds California license C56205.

Dr. Mostofi's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Mostofi's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Mostofi is also affiliated with Torrance Memorial Medical Center. The medical group on file is City of Hope. Dmand AI also links Dr. Mostofi to 2 more hospitals, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mostofi practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mostofi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mostofi is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Mostofi's licenses on file in 4 states: California, Delaware, New Jersey and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer and lymphoma among the conditions Dr. Mostofi treats.

CMS data shows 22,549 Medicare services from Dr. Mostofi across 24 procedure codes in 2024, for 304 Medicare patients. Medicare paid $309,456 for them. Every service was in an office.

CMS counts 304 Medicare patients who saw Dr. Mostofi in 2024. The largest group is 75 to 84, with 119 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mostofi's median patient age at 70, with 63% women.

In 2024, Dr. Mostofi wrote 1,176 Medicare Part D claims for 170 patients. 64% of them were for generic drugs. CMS names the drug for 911 of them, across 28 drugs with 11 or more claims each, at $4,632,710 in total drug cost. In 2023, CMS named 557 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Mostofi for performance year 2024, reported as part of a group. Dr. Mostofi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mostofi as offering telehealth.

Dmand AI links 1 paper to Dr. Mostofi.

CMS Open Payments shows 324 general payments to Dr. Mostofi from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,890.

Dr. Mostofi graduated from St. George's University School of Medicine in 2003.

Dr. Mostofi is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.